MILLENDO THERAPEUTICS INC's ticker is MLND and the CUSIP is 60040X103. A total of 39 filers reported holding MILLENDO THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $3,000 | – | 442 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,396,615 | $20,949,000 | 5.04% |
| GREAT POINT PARTNERS LLC | 1,288,093 | $19,321,000 | 1.91% |
| Bpifrance SA | 1,078,670 | $16,180,000 | 1.84% |
| Prosight Management, LP | 270,762 | $4,061,000 | 1.78% |
| NEA Management Company, LLC | 1,766,779 | $26,502,000 | 1.38% |
| ADAMS STREET PARTNERS LLC | 459,146 | $6,543,000 | 1.27% |
| Samsara BioCapital, LLC | 45,101 | $677,000 | 0.53% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 61,860 | $925,000 | 0.34% |
| PA Capital LLC | 15,263 | $229,000 | 0.24% |
| Fondren Management LP | 14,478 | $217,000 | 0.17% |